Royalty Pharma
RPRX
#1011
Rank
A$35.02 B
Marketcap
A$60.05
Share price
-0.22%
Change (1 day)
25.64%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: A$35.02 Billion

As of January 2026 Royalty Pharma has a market cap of A$35.02 Billion. This makes Royalty Pharma the world's 1011th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$35.02 B2.56%
2025A$34.14 B41.15%
2024A$24.19 B-2.14%
2023A$24.72 B-3.5%
2022A$25.61 B8.51%
2021A$23.60 B-6.55%
2020A$25.26 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Royalty Pharma was reported to be:

A$34.66 Billion
by Nasdaq info icon info icon
A$35.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ANI Pharmaceuticals
ANIP
A$2.56 B-92.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$327.64 B 835.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.425 T 3,969.97%๐Ÿ‡บ๐Ÿ‡ธ USA